For type 2 diabetes patients, retatrutide and a handful of other medications have reduced HbA1c by up to 2.4%
In another preclinical study, GE demonstrated superior metabolic effects compared to GLP-1-GIP or GLP-1-GIP-glucagon multiagonist therapies in models of polycystic ovary syndrome (PCOS), a condition frequently associated with obesity and insulin resistance
If youre considering weight loss injections, its worth thinking beyond the medication itself
However, the use of GLP-1 medications for weight management does not align with these trends
Can they do this
Statistics and reproducibility Data from in vitro epithelial cytotoxicity, fungal proliferation, 13-HODE release, individual metabolites and fungal respiration assays were analyzed using GraphPad Prism version 10 (GraphPad Software, La Jolla California USA)